levonorgestrel has been researched along with Hemorrhage, Uterine in 220 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (5.00) | 18.7374 |
| 1990's | 57 (25.91) | 18.2507 |
| 2000's | 100 (45.45) | 29.6817 |
| 2010's | 31 (14.09) | 24.3611 |
| 2020's | 21 (9.55) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, D; Qian, M; Sun, Y | 1 |
| Che, Y; Chen, X; Du, J; Jiang, L; Liu, F; Liu, J; Liu, X; Mao, Y; Shen, Y; Sun, J; Xiong, X; Xu, J; Xu, L; Yan, X; Zhang, Z; Zhu, W | 1 |
| Barba, D; Caicedo, A; Castillo, K; Jijon Chiriboga, AJ; Robayo, P; Sanon, S; Zambrano, K | 1 |
| Shao, L; Teng, Y; Yang, Z | 1 |
| Baracat, EC; Ferreira-Filho, ES; Magalhaes, J; Soares-Junior, JM | 1 |
| Liu, J; Wang, L; Yu, Y; Zhou, Z | 1 |
| Beshear, D; Lebduska, E; Spataro, BM | 1 |
| Boniface, E; Edelman, A; Han, L; Jensen, JT; Messerle-Forbes, M; O'Donnell, A; Schrote, K | 1 |
| La Marca, A; Selmi, C | 1 |
| Devies, IEC; Merry, AHH; Roumen, FJME; Teunissen, AM | 1 |
| Baccaro, LF; Bahamondes, L; Carvalho, N; Castro, S; Fava, M; Peloggia, A | 1 |
| Akgül, S; Ari, DA; Kanbur, N | 1 |
| Baêta, T; Campos, RR; Rezende, SM; Rocha, ALL; Silva-Filho, A | 1 |
| Aslan Cetin, B; Peker, N; Turan, G; Yalcin Bahat, P | 1 |
| Farrant, C; Mittermeier, T; Wise, MR | 1 |
| Sandoval-Vivas, P | 1 |
| Speer, L | 1 |
| Hickey, M; Romero, SA; Su, HI; Young, K | 1 |
| Boudova, B; Cindrova-Davies, T; Fanta, M; Kuzel, D; Lisa, Z; Mara, M; Zizka, Z | 1 |
| Collins, D; Hanna, L; Steshenko, A | 1 |
| Ziegler, C | 1 |
| Goldstein, SR; Lumsden, MA | 1 |
| Chang, HK; Kwak, SM; Lee, GW; Lee, KH; Park, M; Song, SY; Yoo, HJ | 1 |
| Chen, PH; Choudhury, T; Frondelli, M; Goldman, AR; Shimoni, N | 1 |
| Bistervels, IM; Hamulyák, EN; Middeldorp, S; Scheres, LJJ | 1 |
| Beltrame, A; Bernardes, CR; de Souza, IM; Machado, RB; Morimoto, MS; Santana, N | 1 |
| Dutta, S; Jana, N; Rakshit, BM; Roy, SB; Saha, PK; Sengupta, G | 1 |
| Kolding, L; Majeed, HG | 1 |
| Grimes, DA; Lopez, LM; O'Brien, PA; Raymond, EG | 2 |
| Cancelo Hidalgo, MJ | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Rubin, A; Westhoff, CL | 1 |
| Munro, MG; Solnik, MJ | 1 |
| Pearlman, MD | 1 |
| Craik, J; Melvin, L; Scott, J | 1 |
| Creinin, MD; Eisenberg, DL; Schreiber, CA; Teal, SB; Turok, DK; Westhoff, CL | 1 |
| Heikinheimo, O; Kaislasuo, J; Lähteenmäki, P; Suhonen, S | 1 |
| Crane, EK; Eskew, AM | 1 |
| Castaño, PM; Davis, AR; Nippita, S; Oviedo, JD; Velasco, MG; Westhoff, CL | 1 |
| Friedlander, E; Kaneshiro, B | 1 |
| Roberts, H; Roke, C; Whitehead, A | 1 |
| Billow, MR; El-Nashar, SA | 1 |
| Goldstuck, ND; Jackers, G; Wildemeersch, D | 1 |
| Briggs, P; Thomas, M | 1 |
| Gompel, A | 1 |
| Derniaux, E; Graesslin, O | 1 |
| Hill, DA | 1 |
| Buasang, K; Taneepanichskul, S | 1 |
| Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
| Curtis, KM; Jamieson, DJ; Marchbanks, PA; Tepper, NK; Whiteman, MK; Zapata, LB | 1 |
| Ayub, R; Jaffery, T; Kamal, M; Naseem, F; Rahim, F; Tariq, N | 1 |
| Kaewrudee, S; Panna, S; Somboonporn, W; Soontrapa, S; Temtanakitpaisan, T | 1 |
| Blidaru, I; Boiculese, L; Miron, N; Socolov, D; Socolov, R; Tamba, B | 1 |
| Helmerhorst, FM; Lopez, LM; Raps, M; Van Vliet, HA | 1 |
| D'Alessandro, P; Di Cello, A; Mocciaro, R; Morelli, M; Venturella, R; Zullo, F | 1 |
| Cotton, S; Rosenthal, SL; Succop, PA; Wanchick, AM; Wimberly, YH | 1 |
| Fraser, IS; Hickey, M | 2 |
| Blacksell, S; Cox, M; Tripp, J | 1 |
| Jensen, JT | 2 |
| Taneepanichskul, S; Tantbirojn, P | 1 |
| Aisien, AO; Imade, GE; Nnana, OU; Sagay, AS; Ujah, IA | 2 |
| Ba, MG; Diadhiou, F; Moreau, JC | 1 |
| Schacht, E; Wildemeersch, D; Wildemeersch, P | 1 |
| Hughes, JP; Miller, L | 1 |
| Chen-Mok, M; Grigorieva, V; Mikhailov, A; Tarasova, M | 1 |
| Dhont, M; Wildemeersch, D | 1 |
| Achiron, R; Gamzu, R; Lidor, A; Schiff, G; Shulman, A; Zalel, Y | 1 |
| Luukkainen, T; Pakarinen, P; Toivonen, J | 2 |
| Du, MK; Yao, XY | 1 |
| Loganath, A; Roopa, BA; Singh, K | 1 |
| Chegini, N; Rhoton-Vlasak, A; Williams, RS | 1 |
| Mercorio, F | 1 |
| Guillebaud, J | 1 |
| Brenner, RM; Burton, KA; Critchley, HO; Habib, F; Henderson, TA; Hillier, SG; Mason, JI | 1 |
| Bongers, MY; Brölmann, HA; Mol, BW | 1 |
| Croxatto, HB; d'Arcangues, C; Fuentealba, B; Massai, MR; Pavez, M | 1 |
| Bongers, MY; Bourdrez, P; Mol, BW | 1 |
| Rowe, PJ; Wildemeersch, D | 1 |
| Andrade, AT; Andrade, GN; Rowe, PJ; Souza, JP; Wildemeersch, D | 1 |
| Puzey, M | 2 |
| Shaamash, AH; Zakhari, MM | 1 |
| Benedetto, C; de Melo, NR; Dieben, TO; Leifels-Fischer, B; Oddsson, K; Verhoeven, CH; Wiel-Masson, D | 1 |
| Aissa, RB; Brache, V; d'Arcangues, C; Hazelden, C; Massai, R; Piaggio, G; Pinol, A; Su-juan, G; Subakir, SB | 1 |
| Darney, PD; Korn, AP; Lebovic, DI; Mueller, MD; Pritts, EA; Ryan, IP; Shifren, JL; Taylor, RN; Zaloudek, CJ | 1 |
| Johnson, MJ; Morgan, KW | 1 |
| Colau, JC; Rantala, ML; Riphagen, FE; Sturdee, DW; Zahradnik, HP | 1 |
| Blumenthal, P; Singh, RH | 1 |
| Barlow, D; Guillebaud, J; Hampton, NR; Lowe, DG; Rauramo, I; Rees, MC | 1 |
| Ibraheim, M; Ikomi, A | 1 |
| Bradley, LD | 1 |
| Cândido dos Reis, FJ; de Sá Rosa e Silva, AC; Ferriani, RA; Manetta, LA; Nogueira, AA; Rosa e Silva, JC | 1 |
| Clark, TJ; Gupta, JK; Neelakantan, D | 1 |
| Luukkainen, T; Pakarinen, P | 1 |
| McGavigan, CJ; Owen, P | 1 |
| Abdel-Aleem, AM; Abdel-Aleem, H; Amin, AF; Shaaban, OM | 1 |
| Baird, DT; Cameron, ST; Dewart, H; Gebbie, A; Glasier, AF | 1 |
| Gunes, M; Haberal, A; Kaplan, M; Kayikcioglu, F; Ozdegirmenci, O | 1 |
| Edelman, AB; Jensen, JT; Koontz, SL; Nichols, MD | 1 |
| Goldberg, A; Hays, M; Raymond, EG; Roach, E; Taylor, D; Trussell, J | 1 |
| Ahr, A; Gaetje, R; Kaufmann, M; Scharl, A | 1 |
| Bouyer, J; Doh, AS; Gainer, E; Kenfack, B; Mboudou, E | 1 |
| Cagiano, R; Sabatini, R | 1 |
| Blumenthal, PD; Borenstein, J; Dubois, RW; Guo, A; Liu, Z; Singh, RH; Trussell, J | 1 |
| Raymond, E | 1 |
| Boubli, B; Brun, JL; Dallay, D; Descat, E | 1 |
| Tjalma, WA | 1 |
| Archer, DF; Chegini, N; Luo, X; Pan, Q; Rhoton-Vlasak, A | 1 |
| Odlind, V; Rönnerdag, M | 1 |
| Bjarnason, NH; Byrjalsen, I; Christiansen, C; Jørgensen, HL | 1 |
| Fernandez, H; Gervaise, A | 1 |
| Arepally, G; Lukes, AS; Reardon, B | 1 |
| Allonen, H; Diaz, J; Luukkainen, T; Nilsson, CG | 1 |
| Deville, JL; Dubois, M; Gaspard, UJ | 1 |
| Duda, MJ; Krauss, RM; Lacarra, M; Mishell, DR; Robertson, DN; Roy, S | 1 |
| Aaserud, J; Bratt, H; Fylling, P; Lie, S; Schiefloe, A; Steier, A; Svendsen, E; Ulstein, M | 1 |
| Holma, P; Nilsson, CG | 1 |
| Diczfalusy, E; Johannisson, E; Landgren, BM; Masironi, B | 1 |
| Noerpramana, NP | 1 |
| Hemminki, E; Ollila, E; Sihvo, S | 1 |
| Allonen, HO; Holmström, T; Lähteenmäki, P; Suhonen, SP | 1 |
| Apaja-Sarkkinen, MA; Kauppila, AJ; Laatikainen, TJ; Lahti, EI; Raudaskoski, TH | 1 |
| Harrison, FN; Laurent, S; Phemister, DA | 1 |
| Allonen, HO; Lähteenmäki, P; Suhonen, SP | 1 |
| Affandi, B; Au, CL; Rogers, PA | 1 |
| Gerber, S; Gordon, L; Lopez, M; Westhoff, C | 1 |
| Bateman, L; Cornin, LM; Cox, CA; Frank, ML; Poindexter, AN | 1 |
| Luo, H; Xu, R; Yin, M; Zhu, P | 1 |
| Berenson, AB; Wiemann, CM | 1 |
| Andersson, K; Odlind, V; Rybo, G | 1 |
| Anstee, P; Kovacs, GT | 1 |
| Lähteenmäki, P; Laine, H; Luukkainen, T; Pakarinen, P | 1 |
| Affandi, B; Butt, AR; Findlay, JK; Marsh, MM; Riley, SC; Rogers, PA; Salamonsen, LA; Susil, B | 1 |
| Alvarez-Sanchez, F; Brache, V; Cochon, L; Faundes, A; Thevenin, F | 1 |
| Affandi, B; Clark, DA; Rogers, P; Vince, G; Wang, S | 1 |
| Davie, J; Glasier, A; Hiremath, K | 1 |
| Diaz, J; Diaz, M; Faundes, A; Olmos, P | 1 |
| Bottles, K; Darney, PD; Klaisle, C; Taylor, RN; Zaloudek, C | 1 |
| Biswas, A; Leong, WP; Ratnam, SS; Viegas, OA | 1 |
| Kovacs, G | 1 |
| Archer, DF; Philput, CA; Weber, ME | 1 |
| Dwarte, D; Fraser, I; Graham, S; Hickey, M | 1 |
| Rogers, PA | 1 |
| Affandi, B; Hadisaputra, W; Handoyo, AE; Subakir, SB | 1 |
| Affandi, B; Lau, TM; Rogers, PA; Witjaksono, J | 1 |
| Boonkasemsanti, W; Leepipatpaiboon, S; Niruttisard, S; Pruksananonda, K; Reinprayoon, D; Triratanachat, S; Wannakrairot, P | 1 |
| Archer, DF; DelConte, A; Maheux, R; O'Brien, FB | 1 |
| Demopoulos, R; Krey, L; Lockwood, CJ; Runic, R; Schatz, F; Thung, S; Wan, L | 1 |
| Andersson, K; Mattsson, LA; Odlind, V; Persson, I; Stadberg, E; Wollter-Svensson, LO | 1 |
| Fan, H; Han, L; Meng, F | 1 |
| Lähteenmäki, P; Luukkainen, T; Pakarinen, PI; Suvisaari, J | 1 |
| Dunson, TR; Nutley, T | 1 |
| Albring, M; Bannemerschult, R; Brill, K; Fox, P; Hanker, JP; Wünsch, C | 1 |
| Alvarez, F; Brache, V; Cochón, L; Faúndes, A | 1 |
| Bönisch, U; Gräser, T; Müller, A; Oettel, M; Rössner, P; Schubert, K | 1 |
| Haukkamaa, M; Lähteenmäki, P; Nilsson, CG; Puolakka, J; Riikonen, U; Sainio, S; Suvisaari, J | 1 |
| Prentice, A | 1 |
| Cameron, IT; Campbell-Brown, MB; Heikkilä, A; Irvine, GA; Lumsden, MA; Walker, JJ | 1 |
| Alfthan, H; Lehtovirta, P; Stenman, UH; Vartiainen, J | 1 |
| Odlind, V | 1 |
| Borgatta, L | 1 |
| Affandi, B; Malakooti, N; Rogers, PA; Salamonsen, LA; Vincent, AJ; Zhang, J | 1 |
| Chavez, A; DelConte, A | 1 |
| Kaper, RF; Qian, SZ; Sang, GW; Zheng, HM; Zheng, SR | 1 |
| Jaisamraun, U; Kaewrudee, S; Reinprayoon, D; Taneepanichskul, S | 1 |
| Affandi, B; Kovacs, G; Ostor, A; Rogers, PA; Salamonsen, LA; Vincent, AJ; Zhang, J | 1 |
| Fong, YF; Singh, K | 1 |
| Brechin, S; Cameron, ST; Critchley, HO; Paterson, AM; Williams, AR | 1 |
| Backman, T; Blom, T; Huhtala, S; Koskenvuo, M; Luoto, R; Rauramo, I | 1 |
| Carati, C; Dwarte, D; Fraser, IS; Gannon, BJ; Hickey, M; Manconi, F | 1 |
| Fan, Z; Wang, G; Zheng, S | 1 |
| Dwarte, D; Fraser, IS; Hickey, M | 1 |
| Fraser, IS; Johansson, ED; Minehan, E; Weisberg, E | 1 |
| Affandi, B; Freisleben, HJ; Pringgoutomo, S; Setiadi, E; Subakir, SB | 1 |
| Chen, J; Cheng, L; Glasier, A; Ren, F; Wang, A; Zhu, H | 1 |
| Abdul Madjid, O; Affandi, B; Sabariah, S; Subakir, SB | 1 |
| Graubert, M; Iruela-Arispe, ML; Rodríguez-Manzaneque, JC | 1 |
| Affandi, B; Plunkett, D; Rogers, PA | 1 |
| Salamonsen, LA; Vincent, AJ | 1 |
| Courtoy, PJ; Dubois, D; Eeckhout, Y; Galant, C; Henriet, P; Lemoine, P; Marbaix, E; Picquet, C; Rigot, V; Sufi, S; Twagirayezu, P; Vekemans, M | 1 |
| Critchley, HO; Jones, RL | 1 |
| Affandi, B; Lederman, F; Plunkett, D; Rogers, PA | 1 |
| Neven, P | 1 |
| Abrams, KR; Al-Azzawi, F; Bell, SC; Brown, LJ; Gardner, FJ; Khanna, S; Konje, JC; Taylor, DJ | 1 |
| Kaewrudee, S; Taneepanichskul, S | 1 |
| Schacht, E; Wildemeersch, D | 2 |
| Schacht, E; Thiery, M; Van Kets, H; Wildemeersch, D | 1 |
| Cameron, IT | 1 |
| Rauramo, I; Varila, E; Wahlström, T | 1 |
| Piaggio, G; Pinol, AP | 1 |
| Han, X; Shi, X; Weng, J | 1 |
| Rachev, E | 1 |
| Critchley, HO; Davie, JE; Glasier, AF; Kelly, RW; Wang, H | 1 |
| Laatikainen, T; Luotola, H; Pekonen, F; Raudaskoski, T; Riphagen, F; Ronni-Sivula, H; Tapanainen, J; Timonen, H; Tomás, E | 1 |
| Bjarnadóttir, RI; Killick, SR; Tuppurainen, M | 1 |
| Riphagen, FE | 1 |
| Bahamondes, L; Dantas-Monteiro, C; Diaz, J; Hidalgo, M; Perrotti, M; Petta, C | 1 |
| Sturdee, DW; van de Weijer, PH; von Holst, T | 1 |
| Schrager, S | 1 |
| Faghihzadeh, S; Lamyian, M; Rajaei, L; Ziaei, S | 1 |
| Christiansen, C; Marslew, U; Overgaard, K; Riis, BJ | 1 |
| Tissot, B; Vekemans, M | 1 |
| Crona, N; Mattsson, LA; Rybo, G; Sporrong, T; Vilbergson, G | 1 |
| Andersson, K; Mattsson, LA; Rybo, G; Stadberg, E | 1 |
| Bull, CA; Houghton, CR; Langlands, AO; McKay, MJ | 1 |
| Ratnam, SS; Singh, K; Viegas, OA | 1 |
| Delbarge, W; Thiery, M; Van der Pas, H; Van Kets, H | 1 |
| Chen, JH; Cheng, J; Luo, HZ; Wang, XP; Wu, MZ; Wu, SC; Xu, RH; Zhu, PD | 1 |
| Aedo, AR; Cekan, SZ; Diczfalusy, E; Landgren, BM | 1 |
| Abo-Eloyoun, M; Ahmed, AG; Salah, M; Shaaban, MM | 1 |
| Donde, UM; Joshi, JV; Joshi, UM; Sankoli, GM; Saxena, BN; Virkar, KD | 1 |
40 review(s) available for levonorgestrel and Hemorrhage, Uterine
| Article | Year |
|---|---|
Long-acting reversible contraceptives effects in abnormal uterine bleeding, a review of the physiology and management.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Uterine Hemorrhage | 2022 |
Abnormal Uterine Bleeding.
Topics: Contraceptives, Oral; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Pregnancy; Uterine Hemorrhage | 2023 |
Oral hormonal therapy as treatment option for abnormal uterine bleeding.
Topics: Contraceptives, Oral, Combined; Female; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Progestins; Quality of Life; Uterine Hemorrhage | 2023 |
Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Topics: Adult; Aged; Bias; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Nausea; Patient Dropouts; Patient Satisfaction; Progestins; Randomized Controlled Trials as Topic; Remission Induction; Time Factors; Uterine Hemorrhage; Weight Gain; Young Adult | 2020 |
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen; Uterine Hemorrhage; Uterus | 2020 |
Abnormal uterine bleeding in perimenopause.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Contraceptives, Oral, Combined; Diagnostic Imaging; Endometrial Hyperplasia; Endometrium; Female; Genital Neoplasms, Female; Humans; Hysteroscopy; Leiomyoma; Levonorgestrel; Middle Aged; Perimenopause; Pregnancy; Quality of Life; Uterine Hemorrhage | 2017 |
Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis.
Topics: Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; MEDLINE; Pain Management; Patient Satisfaction; Postoperative Care; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Secondary Prevention; Uterine Hemorrhage | 2018 |
Sex matters: Practice 5P's when treating young women with venous thromboembolism.
Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Heparin, Low-Molecular-Weight; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Metrorrhagia; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Recurrence; Risk Factors; Sex Factors; Stockings, Compression; Thrombophilia; Thrombophlebitis; Tranexamic Acid; Travel; Uterine Hemorrhage; Venous Thromboembolism; Young Adult | 2019 |
Progestin-only pills for contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Progestins; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2013 |
[Hormonal treatments for hemorrhaging secondary to fibroids. An alternative or complement to surgery?].
Topics: Combined Modality Therapy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogen Receptor Modulators; Estrogens; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Norpregnenes; Progesterone; Progestins; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 2013 |
Indications and alternatives to hysterectomy.
Topics: Adenomyosis; Aromatase Inhibitors; Chronic Pain; Endometrial Hyperplasia; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Pelvic Pain; Polyps; Uterine Artery Embolization; Uterine Diseases; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms | 2014 |
Jaydess® levonorgestrel intrauterine system.
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Equipment Failure Analysis; Equipment Safety; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate; Pregnancy, Ectopic; Randomized Controlled Trials as Topic; Risk Assessment; United Kingdom; Uterine Hemorrhage | 2014 |
Therapeutic Options for Unscheduled Bleeding Associated with Long-Acting Reversible Contraception.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraception; Doxycycline; Female; Hormone Antagonists; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Matrix Metalloproteinase Inhibitors; Mifepristone; Practice Guidelines as Topic; Time Factors; Tranexamic Acid; Uterine Hemorrhage | 2015 |
Management of Abnormal Uterine Bleeding with Emphasis on Alternatives to Hysterectomy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Contraindications; Endometrial Ablation Techniques; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Minimally Invasive Surgical Procedures; Outcome Assessment, Health Care; Quality of Life; United States; Uterine Hemorrhage | 2016 |
Progestin-only pills for contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Progestins; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2010 |
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Intrauterine device use among women with uterine fibroids: a systematic review.
Topics: Contraceptive Agents, Female; Female; Ferritins; Hematocrit; Hemoglobins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Hemorrhage; Uterine Neoplasms | 2010 |
Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis.
Topics: Adult; Climacteric; Contraceptive Agents, Female; Endometrium; Estrogens; Female; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Perimenopause; Postmenopause; Progestins; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2011 |
Quadriphasic versus monophasic oral contraceptives for contraception.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medication Adherence; Menstruation; Nandrolone; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2011 |
The levonorgestrel intrauterine system: a clinical perspective from the UK.
Topics: Adult; Contraception; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pelvic Infection; Pregnancy; Pregnancy Rate; Risk Assessment; United Kingdom; Uterine Hemorrhage | 2003 |
Current treatment of dysfunctional uterine bleeding.
Topics: Catheter Ablation; Contraceptive Agents, Female; Counseling; Endometrium; Female; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Laparoscopy; Laser Therapy; Levonorgestrel; Quality of Life; Uterine Hemorrhage; Vagina | 2004 |
Intrauterine contraception benefits extend beyond birth control.
Topics: Adolescent; Adult; Copper; Cost-Benefit Analysis; Endometrial Neoplasms; Estrogen Replacement Therapy; Female; Global Health; Humans; Intrauterine Devices; Levonorgestrel; Uterine Hemorrhage | 2005 |
Hormonal management of abnormal uterine bleeding.
Topics: Contraceptive Agents, Female; Danazol; Estrogen Antagonists; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Progesterone; Progesterone Congeners; Uterine Hemorrhage | 2005 |
Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overview.
Topics: Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Uterine Hemorrhage | 2005 |
Abnormal uterine bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Catheter Ablation; Contraceptives, Oral; Danazol; Dilatation and Curettage; Embolization, Therapeutic; Endometrial Hyperplasia; Endometrial Neoplasms; Endosonography; Estrogen Antagonists; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Hysteroscopy; Levonorgestrel; Magnetic Resonance Imaging; Perimenopause; Puberty; Risk Factors; Treatment Outcome; Uterine Hemorrhage; von Willebrand Diseases | 2005 |
The levonorgestrel-releasing intrauterine system in modern gynaecology.
Topics: Contraceptive Agents, Female; Endometriosis; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Premenstrual Syndrome; Uterine Hemorrhage; Uterine Neoplasms | 2005 |
Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception.
Topics: Contraception; Contraceptives, Oral; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Levonorgestrel; Markov Chains; MEDLINE; Treatment Outcome; Uterine Hemorrhage | 2006 |
[Endometrial hyperplasia: A review].
Topics: Biopsy; Endometrial Hyperplasia; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysteroscopy; Levonorgestrel; Menopause; Progestins; Uterine Hemorrhage; Uterus | 2006 |
[Dysfunctionnal uterin bleedings].
Topics: Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Pregnancy; Premenopause; Tranexamic Acid; Uterine Hemorrhage | 2007 |
Progestogen-only pills and bleeding disturbances.
Topics: Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Norethindrone; Progesterone Congeners; Uterine Hemorrhage | 1996 |
Long-term experience of a levonorgestrel-releasing intrauterine system.
Topics: Contraceptive Agents, Female; Equipment Failure; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Risk Factors; Uterine Hemorrhage | 1996 |
Managing clinical complexities of long-term contraception.
Topics: Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Uterine Hemorrhage | 1998 |
The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives.
Topics: Biopsy; Contraceptive Agents, Female; Endometrium; Female; Humans; Leukocytes; Levonorgestrel; Matrix Metalloproteinases; Medroxyprogesterone Acetate; Progestins; Uterine Hemorrhage | 2000 |
Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery.
Topics: Contraceptive Agents, Female; Decidua; Endometritis; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Receptors, Estrogen; Receptors, Progesterone; Uterine Hemorrhage | 2000 |
Intrauterine contraception in the year 2001: can intrauterine device use be revived with new improved contraceptive technology?
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Uterine Hemorrhage | 2000 |
The levonorgestrel intrauterine system: the benefits of reduced bleeding.
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Endometrium; Female; Humans; Levonorgestrel; Menorrhagia; Menstruation; Uterine Hemorrhage | 2001 |
Progestin-releasing intrauterine systems.
Topics: Acne Vulgaris; Clinical Trials as Topic; Contraceptive Agents, Female; Depression; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Progesterone; Progesterone Congeners; Uterine Hemorrhage; Uterine Perforation; Weight Gain | 2001 |
[Mirena--the first intrauterine contraceptive therapeutic system].
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Treatment Outcome; Uterine Hemorrhage | 2001 |
Intrauterine application of progestins in hormone replacement therapy: a review.
Topics: Animals; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipids; Patient Satisfaction; Progesterone; Progestins; Uterine Hemorrhage; Uterus | 2000 |
Abnormal uterine bleeding associated with hormonal contraception.
Topics: Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Progestins; Uterine Hemorrhage | 2002 |
64 trial(s) available for levonorgestrel and Hemorrhage, Uterine
| Article | Year |
|---|---|
Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
Topics: Contraception; Contraceptive Agents, Female; Curcumin; Female; Humans; Levonorgestrel; Metrorrhagia; Pregnancy; Uterine Hemorrhage | 2023 |
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethnicity; Female; Humans; Levonorgestrel; Obesity; Patient Compliance; Pregnancy; Transdermal Patch; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Parity; Pelvic Infection; Pregnancy; Pregnancy Rate; Time Factors; Uterine Hemorrhage; Young Adult | 2015 |
A randomized controlled trial of daily text messages versus monthly paper diaries to collect bleeding data after intrauterine device insertion.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Data Collection; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Medical Records; Middle Aged; Text Messaging; Time Factors; Uterine Hemorrhage; Young Adult | 2015 |
Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Contraceptive Agents, Female; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Implants; Female; Humans; Levonorgestrel; Middle Aged; Pyrazoles; Sulfonamides; Thailand; Uterine Hemorrhage; Young Adult | 2009 |
Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Topics: Adult; Contraceptive Agents, Female; Device Removal; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Middle Aged; Organ Size; Patient Satisfaction; Severity of Illness Index; Treatment Outcome; Tumor Burden; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms; Uterus | 2011 |
Attitudes and experiences with levonorgestrel 100 microg/ethinyl estradiol 20 microg among women during a 3-month trial.
Topics: Adult; Attitude; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Patient Satisfaction; Surveys and Questionnaires; Uterine Hemorrhage | 2002 |
Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report.
Topics: Adult; Device Removal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Rate; Progesterone Congeners; United Kingdom; Uterine Hemorrhage | 2002 |
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage | 2002 |
Performance and acceptability of intrauterine release of levonorgestrel with a miniature delivery system for hormonal substitution therapy, contraception and treatment in peri and postmenopausal women.
Topics: Adult; Climacteric; Contraception; Drug Delivery Systems; Drug Implants; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Postmenopause; Prospective Studies; Time Factors; Uterine Hemorrhage; Uterus | 2003 |
Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial.
Topics: Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Treatment Outcome; Ultrasonography; Uterine Hemorrhage | 2003 |
Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up.
Topics: Abortion, Induced; Adult; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Pain; Pelvic Inflammatory Disease; Pregnancy; Uterine Hemorrhage | 2003 |
[A randomized study comparing the efficacy and bleeding pattern of Implanon and Norplant hormonal contraceptive implant].
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Uterine Hemorrhage | 2003 |
Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levonorgestrel; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2004 |
Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
Topics: Adult; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Menstrual Cycle; Patient Compliance; Pregnancy; Pregnancy Rate; Uterine Hemorrhage | 2005 |
Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chile; China; Dominican Republic; Drug Administration Schedule; Female; Humans; Indonesia; Levonorgestrel; Patient Satisfaction; Treatment Outcome; Tunisia; Uterine Hemorrhage; Vitamin E | 2004 |
The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women.
Topics: Administration, Cutaneous; Adult; Breast; Contraceptives, Oral, Synthetic; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Headache; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipids; Middle Aged; Pain; Postmenopause; Skin; Ultrasonography; Uterine Hemorrhage | 2004 |
Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women.
Topics: Administration, Oral; Adult; Animals; Contraceptive Agents, Female; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens; Female; Horses; Humans; Levonorgestrel; Middle Aged; Perimenopause; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2005 |
Five years' experience with a small intracervical/intrauterine levonorgestrel-releasing device.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Device Removal; Endometrium; Equipment Design; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate; Ultrasonography; Uterine Hemorrhage | 2005 |
Tamoxifen treatment of bleeding irregularities associated with Norplant use.
Topics: Adult; Double-Blind Method; Estrogen Antagonists; Female; Humans; Levonorgestrel; Placebos; Tamoxifen; Uterine Hemorrhage | 2005 |
Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
Topics: Administration, Cutaneous; Amenorrhea; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Incidence; Levonorgestrel; Middle Aged; Pilot Projects; Postmenopause; Treatment Outcome; Uterine Hemorrhage | 2006 |
Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
Topics: Adult; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Patient Satisfaction; Uterine Hemorrhage | 2006 |
Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives.
Topics: Administration, Intravaginal; Adult; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Libido; Menstrual Cycle; Norpregnenes; Prospective Studies; Reproduction; Uterine Hemorrhage | 2006 |
Late bleeding problems with the levonorgestrel-releasing intrauterine system: evaluation of the endometrial cavity.
Topics: Adult; Case-Control Studies; Contraceptive Agents, Female; Endometrium; Female; Humans; Hysteroscopy; Intrauterine Devices; Levonorgestrel; Ultrasonography; Uterine Hemorrhage | 2007 |
Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Topics: Adolescent; Adult; Brazil; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Finland; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Outpatient Clinics, Hospital; Pain; Pregnancy; Random Allocation; Uterine Hemorrhage | 1983 |
Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
Topics: Adolescent; Adult; Capsules; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Silicone Elastomers; Uterine Hemorrhage | 1984 |
Clinical experience with a triphasic oral contraceptive.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Uterine Hemorrhage | 1984 |
Perceptions and satisfaction among Norplant users in Finland.
Topics: Adult; Amenorrhea; Family Planning Services; Female; Finland; Humans; Intrauterine Devices; Levonorgestrel; Maternal Health Services; Patient Satisfaction; Surveys and Questionnaires; Uterine Hemorrhage | 1995 |
Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy.
Topics: Administration, Cutaneous; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Postmenopause; Progestins; Sex Hormone-Binding Globulin; Ultrasonography; Uterine Hemorrhage; Uterus | 1995 |
Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Climacteric; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices; Levonorgestrel; Middle Aged; Uterine Hemorrhage | 1995 |
Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.
Topics: Acne Vulgaris; Adult; Blood Pressure; Body Weight; Female; Headache; Humans; Levonorgestrel; Postpartum Period; Prospective Studies; Uterine Hemorrhage | 1995 |
Sustained-release estradiol implants and a levonorgestrel-releasing intrauterine device in hormone replacement therapy.
Topics: Drug Implants; Estradiol; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices; Levonorgestrel; Middle Aged; Postmenopause; Uterine Hemorrhage | 1995 |
The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine devices.
Topics: Adult; Cell Count; Endometrium; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Mast Cells; Middle Aged; Uterine Hemorrhage | 1993 |
A prospective randomized study comparing the clinical effects of a norethisterone and a levonorgestrel containing low dose oestrogen oral contraceptive pills.
Topics: Adolescent; Adult; Breast; Contraceptives, Oral, Combined; Estrogens; Female; Humans; Levonorgestrel; Norethindrone; Prospective Studies; Uterine Hemorrhage; Weight Gain | 1993 |
Hormonal treatment for bleeding irregularities in Norplant implant users.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Prospective Studies; Uterine Hemorrhage | 1996 |
Management of irregular uterine bleeding and spotting associated with Norplant.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Ibuprofen; Incidence; Levonorgestrel; Pilot Projects; Prospective Studies; Uterine Hemorrhage | 1996 |
Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
Topics: Adolescent; Adult; Blood Vessels; Contraceptive Agents, Female; Drug Implants; Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Uterine Hemorrhage | 1996 |
Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Topics: Adult; Biopsy; Cohort Studies; Contraceptive Agents, Female; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Uterine Hemorrhage | 1996 |
The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
Topics: Administration, Cutaneous; Biopsy; Contraceptive Agents, Female; Endometrium; Estradiol; Estrogens; Female; Humans; Immunohistochemistry; Levonorgestrel; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Sex Hormone-Binding Globulin; Uterine Hemorrhage | 1996 |
A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Headache; Humans; Incidence; Levonorgestrel; Life Tables; Menstruation; Metrorrhagia; Middle Aged; Patient Compliance; Patient Dropouts; Pregnancy; Pregnancy Rate; Safety; Uterine Cervical Neoplasms; Uterine Hemorrhage | 1997 |
Intrauterine administration of levonorgestrel 5 and 10 microg/24 hours in perimenopausal hormone replacement therapy. A randomized clinical study during one year.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Contraceptive Agents, Female; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Patient Satisfaction; Premenopause; Prospective Studies; Single-Blind Method; Uterine Hemorrhage | 1997 |
Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Topics: Adult; Contraception; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Follicle; Progesterone Congeners; Prospective Studies; Software; Time Factors; Ultrasonography; Uterine Hemorrhage | 1997 |
A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Patient Compliance; Pregnancy; Uterine Hemorrhage | 1997 |
Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants.
Topics: Contraceptive Agents, Female; Drug Implants; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Progesterone Congeners; Uterine Hemorrhage | 1998 |
A comparative study of two levonorgestrel-containing hormone replacement therapy regimens of efficacy and tolerability variables.
Topics: Cohort Studies; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Middle Aged; Patient Dropouts; Postmenopause; Progesterone Congeners; Time Factors; Uterine Hemorrhage | 1997 |
Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy.
Topics: Adult; Drug Administration Routes; Female; Follow-Up Studies; Humans; Hysterectomy; Levonorgestrel; Middle Aged; Progesterone Congeners; Quality of Life; Treatment Outcome; Uterine Hemorrhage | 1998 |
Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
Topics: Adult; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Norethindrone; Patient Satisfaction; Progesterone Congeners; Treatment Outcome; Uterine Hemorrhage | 1998 |
A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study.
Topics: Adolescent; Adult; Analysis of Variance; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Norethindrone; Uterine Hemorrhage | 1999 |
A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Desogestrel; Female; Hemoglobins; Humans; Levonorgestrel; Patient Acceptance of Health Care; Progesterone Congeners; Uterine Hemorrhage; Vinyl Compounds | 1999 |
The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Double-Blind Method; Endometrium; Estradiol; Female; Fluoroimmunoassay; Humans; Levonorgestrel; Mefenamic Acid; Progesterone; Ultrasonography; Uterine Hemorrhage | 1999 |
A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings.
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation; Norprogesterones; Progesterone Congeners; Uterine Hemorrhage | 2000 |
Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies.
Topics: Adolescent; Adult; Cells, Cultured; Contraceptive Agents, Female; Data Interpretation, Statistical; Dietary Supplements; Double-Blind Method; Endometrium; Female; Humans; Levonorgestrel; Lipid Peroxides; Neovascularization, Physiologic; Treatment Outcome; Uterine Hemorrhage; Vitamin E | 2000 |
Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Implants; Female; Hormone Antagonists; Humans; Levonorgestrel; Mifepristone; Placebos; Progesterone; Time Factors; Uterine Hemorrhage | 2000 |
Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial.
Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrium; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Patient Dropouts; Postmenopause; Tamoxifen; Treatment Outcome; Uterine Hemorrhage | 2000 |
Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study.
Topics: Biopsy; Contraceptives, Oral, Synthetic; Drug Interactions; Endometrium; Female; Hormone Antagonists; Humans; Immunohistochemistry; Levonorgestrel; Mifepristone; Pilot Projects; Progesterone; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Single-Blind Method; Statistics, Nonparametric; Up-Regulation; Uterine Hemorrhage | 2002 |
Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
Topics: Administration, Intravaginal; Administration, Oral; Aged; Cholesterol, HDL; Cholesterol, LDL; Dinoprostone; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 2002 |
Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Menstrual Cycle; Uterine Hemorrhage | 2002 |
Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years.
Topics: Adolescent; Adult; Amenorrhea; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Oligomenorrhea; Patient Satisfaction; Pregnancy; Prospective Studies; Uterine Hemorrhage | 2002 |
Estradiol and levonorgestrel: effects on bleeding pattern when administered in a sequential combined regimen with a new transdermal patch.
Topics: Administration, Cutaneous; Adult; Aged; Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Patient Satisfaction; Postmenopause; Surveys and Questionnaires; Uterine Hemorrhage | 2002 |
Comparative study and evaluation of side effects of low-dose contraceptive pills administered by the oral and vaginal route.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Uterine Hemorrhage | 2002 |
Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Topics: Bone and Bones; Bone Density; Calcium; Climacteric; Cyproterone; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Middle Aged; Osteoporosis, Postmenopausal; Time Factors; Uterine Hemorrhage | 1992 |
An objective and subjective assessment of uterine blood loss in postmenopausal women on hormone replacement therapy.
Topics: Climacteric; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Uterine Hemorrhage | 1992 |
Intrauterine release of levonorgestrel--a new way of adding progestogen in hormone replacement therapy.
Topics: Biopsy; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Middle Aged; Uterine Hemorrhage; Uterus | 1992 |
The effect of intrauterine devices, the stainless steel ring, the copper T220, and releasing levonorgestrel, on the bleeding profile and the morphological structure of the human endometrium--a comparative study of three IUDs. A morphometric study of 96 ca
Topics: Adult; Endometrium; Female; Foreign-Body Reaction; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Stainless Steel; Uterine Hemorrhage | 1989 |
116 other study(ies) available for levonorgestrel and Hemorrhage, Uterine
| Article | Year |
|---|---|
Clinical efficacy of levonorgestrel intrauterine system (Mirena) combined with hysteroscopy in the treatment of perimenopausal AUB patients.
Topics: Case-Control Studies; Combined Modality Therapy; Dydrogesterone; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Perimenopause; Random Allocation; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2021 |
Associations of MCM8 rs3761873 and rs16991617 variants with abnormal uterine bleeding induced by copper intrauterine device.
Topics: Case-Control Studies; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Minichromosome Maintenance Proteins; Uterine Hemorrhage | 2022 |
Evaluation of the Efficacy and Adverse Reactions of Mirena Combined with Hysteroscopic Surgery When Treating AUB: Based on a Retrospective Cohort Study.
Topics: Case-Control Studies; Female; Humans; Hysteroscopy; Levonorgestrel; Mastodynia; Nausea; Pregnancy; Quality of Life; Retrospective Studies; Uterine Hemorrhage | 2022 |
Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up.
Topics: Adenomyosis; Cohort Studies; Contraceptive Agents; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Hemorrhage | 2022 |
Effect of Mirena Intrauterine Device on Endometrial Thickness, Quality of Life Score, and Curative Effect in Patients with Perimenopausal Abnormal Uterine Bleeding.
Topics: Female; Hemoglobins; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Perimenopause; Quality of Life; Uterine Hemorrhage | 2022 |
Differences in continuation rates and early removal between contraceptive and therapeutic use of the levonorgestrel-releasing intrauterine system 52 mg.
Topics: Adult; Age Factors; Contraceptive Agents, Female; Family Characteristics; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Netherlands; Proportional Hazards Models; Retrospective Studies; Uterine Hemorrhage | 2019 |
A randomized controlled pilot study of ulipristal acetate for abnormal bleeding among women using the 52-mg levonorgestrel intrauterine system.
Topics: Adult; Brazil; Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norpregnadienes; Pilot Projects; Uterine Hemorrhage; Young Adult | 2020 |
Letter to the Editor: "The Use of Norethisterone for the Treatment of Severe Uterine Bleeding in Adolescents: An Audit of Our Experience".
Topics: Adolescent; Female; Humans; Levonorgestrel; Norethindrone; Uterine Hemorrhage | 2020 |
Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
Topics: Adult; Blood Coagulation Disorders, Inherited; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life; Uterine Hemorrhage | 2020 |
The effect of a levonorgestrel-releasing intrauterine device on female sexual function.
Topics: Adult; Contraceptive Agents, Female; Dyspareunia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Psychophysiology; Sexual Arousal; Sexual Behavior; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Treatment Outcome; Uterine Hemorrhage | 2021 |
[Safety and acceptability of the 52 mg levonorgestrel-releasing intrauterine system in women with abnormal uterine bleeding in an ambulatory care center in Bogotá, Colombia, 2012-2016].
Topics: Adult; Amenorrhea; Cohort Studies; Colombia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Retrospective Studies; Ultrasonography; Uterine Hemorrhage; Uterus | 2020 |
Vaginal Bleeding Decreases over Time with a Levonorgestrel Intrauterine System.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Uterine Hemorrhage | 2020 |
Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system.
Topics: Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Polyps; Uterine Hemorrhage; Uterine Neoplasms | 2022 |
Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Uterine Hemorrhage | 2021 |
Excerpts from the World Medical Literature.
Topics: Electric Impedance; Endometrial Ablation Techniques; Female; Humans; Levonorgestrel; Uterine Diseases; Uterine Hemorrhage | 2021 |
Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Topics: Antifibrinolytic Agents; Contraceptive Agents, Hormonal; Endometrial Ablation Techniques; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Tranexamic Acid; Uterine Artery Embolization; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms; Watchful Waiting | 2021 |
Bleeding and spotting with the levonorgestrel 13.5 mg intrauterine system: the impact of insertion timing.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Metrorrhagia; Multivariate Analysis; New Jersey; Pregnancy; Pregnancy, Unplanned; Regression Analysis; Time Factors; Uterine Hemorrhage; Young Adult | 2019 |
The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids.
Topics: Adult; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Longitudinal Studies; Middle Aged; Patient Satisfaction; Perimenopause; Prospective Studies; Uterine Hemorrhage; Uterine Neoplasms | 2013 |
Management of abnormal uterine bleeding in women with mechanical heart valve prosthesis and anticoagulant therapy.
Topics: Adult; Anticoagulants; Catheter Ablation; Contraceptive Agents, Female; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Middle Aged; Prospective Studies; Uterine Hemorrhage; Uterine Neoplasms | 2011 |
[Reasons for removal of intrauterine devices among women in general practice].
Topics: Contraceptive Agents, Female; Device Removal; Female; General Practice; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage | 2013 |
What is new in abnormal uterine bleeding? Best articles from the past year.
Topics: Female; Humans; Hysterectomy; Levonorgestrel; Treatment Outcome; Uterine Hemorrhage | 2014 |
Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Pain; Pilot Projects; Ultrasonography; Uterine Hemorrhage; Uterus; Young Adult | 2015 |
Levonorgestrel Intrauterine Device Placement in a Premenopausal Breast Cancer Patient with a Bicornuate Uterus.
Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Tamoxifen; Treatment Outcome; Urogenital Abnormalities; Uterine Hemorrhage; Uterus | 2016 |
New Zealand women's experience during their first year of Jadelle® contraceptive implant.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Ethnicity; Female; Humans; Levonorgestrel; Medical Assistance; Middle Aged; New Zealand; Patient Satisfaction; Uterine Hemorrhage; Young Adult | 2016 |
Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
Topics: Abdominal Pain; Adolescent; Adult; Belgium; Contraception Behavior; Contraceptive Agents, Female; Device Removal; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Lost to Follow-Up; Middle Aged; Parity; Patient Acceptance of Health Care; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Uterine Hemorrhage; Young Adult | 2017 |
A case of endometrial carcinoma in a long-term Levonorgestrel Intrauterine System (LNG 52 mg-IUS) user.
Topics: Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Uterine Hemorrhage | 2017 |
[Treatment of metrorrhagia, breakthrough bleeding and spotting under contraceptives].
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Drug Implants; Estrogens; Female; Humans; Levonorgestrel; Metrorrhagia; Progestins; Uterine Hemorrhage | 2008 |
[Medical treatment of idiopathic menorrhagia].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptive Agents, Female; Estrogens; Female; Humans; Levonorgestrel; Menorrhagia; Progestins; Uterine Hemorrhage; Uterus | 2008 |
Abnormal uterine bleeding: avoid the rush to hysterectomy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Contraceptive Agents, Female; Danazol; Diagnosis, Differential; Drug Therapy, Combination; Endometrial Ablation Techniques; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Metrorrhagia; Minimally Invasive Surgical Procedures; Practice Guidelines as Topic; Pregnancy Tests; Progestins; Treatment Outcome; Uterine Hemorrhage | 2009 |
Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Middle Aged; Treatment Outcome; Uterine Hemorrhage | 2011 |
Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Topics: Administration, Intravaginal; Aged; Body Mass Index; Cell Proliferation; Drug Delivery Systems; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Follow-Up Studies; Humans; Italy; Levonorgestrel; Middle Aged; Obesity; Overweight; Postmenopause; Retrospective Studies; Risk; Secondary Prevention; Uterine Hemorrhage | 2013 |
Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
Topics: Adult; Blood Vessels; Contraceptive Agents, Female; Drug Implants; Endometrium; Epithelium; Female; Humans; Hysteroscopy; Levonorgestrel; Menorrhagia; Prospective Studies; Uterine Hemorrhage | 2002 |
Noncontraceptive applications of the levonorgestrel intrauterine system.
Topics: Drug Delivery Systems; Female; Humans; Intrauterine Devices; Levonorgestrel; Progesterone Congeners; Randomized Controlled Trials as Topic; United States; Uterine Hemorrhage | 2002 |
Evaluation of menstrual and haematological parameters, after 36 months of Norplant contraception.
Topics: Adult; Contraceptive Agents, Female; Female; Hematocrit; Humans; Leukocyte Count; Levonorgestrel; Longitudinal Studies; Menstrual Cycle; Platelet Count; Prospective Studies; Uterine Hemorrhage | 2002 |
[Tolerance and acceptability of Norplant contraceptive devices].
Topics: Adolescent; Adult; Amenorrhea; Asthenia; Contraception; Contraceptives, Oral, Synthetic; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Patient Satisfaction; Prospective Studies; Senegal; Silicone Elastomers; Uterine Hemorrhage | 2002 |
Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas.
Topics: Adult; Female; Hemoglobins; Humans; Leiomyoma; Levonorgestrel; Menstruation; Middle Aged; Prospective Studies; Uterine Hemorrhage; Uterine Neoplasms | 2003 |
Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system.
Topics: Adenoma; Aged; Antineoplastic Agents; Drug Delivery Systems; Endometrial Hyperplasia; Equipment Design; Female; Humans; Levonorgestrel; Middle Aged; Uterine Hemorrhage; Uterus | 2003 |
The progestative effect of the levonorgestrel-releasing intrauterine system--when does it manifest?
Topics: Adult; Arteries; Blood Flow Velocity; Cervix Uteri; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Time Factors; Ultrasonography; Uterine Hemorrhage; Uterus | 2003 |
The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Epidermal Growth Factor; Estradiol; Female; Fibroblast Growth Factor 2; Growth Substances; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medical Records; Menstrual Cycle; Neovascularization, Physiologic; Progesterone; Transforming Growth Factor beta; Transforming Growth Factor beta1; Uterine Hemorrhage; Vascular Endothelial Growth Factor A | 2003 |
Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Endometrium; Female; Humans; Immunohistochemistry; Levonorgestrel; Matrix Metalloproteinases; Matrix Metalloproteinases, Secreted; Menstrual Cycle; Prospective Studies; Reference Values; Staining and Labeling; Tissue Inhibitor of Metalloproteinase-3; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Uterine Hemorrhage | 2003 |
Differing results for efficacy--sampling bias or purposive sampling?
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Leiomyoma; Levonorgestrel; Selection Bias; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 2003 |
Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium.
Topics: 17-Hydroxysteroid Dehydrogenases; Biopsy; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Gene Expression; Humans; Immunohistochemistry; Intrauterine Devices, Medicated; Levonorgestrel; Menstrual Cycle; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Uterine Hemorrhage | 2003 |
Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices; Levonorgestrel; Likelihood Functions; Middle Aged; Patient Satisfaction; Treatment Failure; Uterine Hemorrhage | 2004 |
Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system.
Topics: Adolescent; Adult; Belgium; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Middle Aged; Uterine Hemorrhage | 2004 |
Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
Topics: Brazil; Female; Ferritins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Uterine Hemorrhage | 2004 |
I want my Mirena out!
Topics: Device Removal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medical Audit; Menorrhagia; Pregnancy; Risk Assessment; South Africa; Uterine Hemorrhage | 2004 |
Increased serum levels of nitric oxide metabolites among users of levonorgestrel-releasing implants [corrected] a possible role in progestin-induced bleeding.
Topics: Adult; Case-Control Studies; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Endometrium; Female; Humans; Levonorgestrel; Menstrual Cycle; Nitric Oxide; Uterine Hemorrhage; Vasodilation | 2005 |
Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Immunohistochemistry; Levonorgestrel; Middle Aged; Neovascularization, Physiologic; Uterine Hemorrhage; Vascular Endothelial Growth Factor A | 2005 |
An evaluation of troublesome inter-menstrual bleeding in menorrhagic users of the LNG-IUS.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Retrospective Studies; Uterine Hemorrhage; Uterus | 2005 |
Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Topics: Adult; Anemia; Blood Flow Velocity; Contraceptive Agents, Female; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Myoma; Time Factors; Uterine Hemorrhage; Uterine Neoplasms; Uterus | 2005 |
The management of endometrial hyperplasia: an evaluation of current practice.
Topics: Aged; Aged, 80 and over; Biopsy; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Middle Aged; Remission Induction; Retrospective Studies; Treatment Outcome; Uterine Hemorrhage | 2006 |
The effect of the levonorgestrel intrauterine system on uterine artery blood flow 1 year after insertion.
Topics: Adult; Arteries; Blood Flow Velocity; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pulsatile Flow; Uterine Hemorrhage; Uterus; Vascular Resistance | 2006 |
Bleeding patterns after use of levonorgestrel emergency contraceptive pills.
Topics: Adult; Contraception, Postcoital; Female; Humans; Levonorgestrel; Menstrual Cycle; Time Factors; Uterine Hemorrhage | 2006 |
Mirena and ectopic pregnancy -- a diagnostic challenge.
Topics: Abdominal Pain; Adult; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Uterine Hemorrhage | 2006 |
[Management of abnormal uterine bleeding].
Topics: Algorithms; Catheter Ablation; Contraceptive Agents, Female; Embolization, Therapeutic; Endometrium; Female; Humans; Levonorgestrel; Menopause; Uterine Hemorrhage | 2006 |
Menstrual bleeding patterns following levonorgestrel emergency contraception.
Topics: Adolescent; Adult; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Prospective Studies; Regression Analysis; Time Factors; Uterine Hemorrhage | 2006 |
Minor error in our paper which was recently published in Contraception.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Medical Records; Menstrual Cycle; Menstruation Disturbances; Pregnancy; Uterine Hemorrhage | 2006 |
Abdominal apoplexy associated with the levonorgestrel intrauterine system--case report.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Uterine Hemorrhage | 2006 |
Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy.
Topics: Adolescent; Adult; Chemokine CXCL5; Chemokines, CXC; Contraceptive Agents, Female; Doxycycline; Endometrium; Female; Follicular Phase; Humans; Inflammation; Levonorgestrel; Luteal Phase; Stromal Cells; Uterine Hemorrhage | 2007 |
The influence of smoking on uterine bleeding during sequential oral hormone therapy.
Topics: Administration, Oral; Contraceptive Agents; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Smoking; Uterine Hemorrhage | 2007 |
Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
Topics: Administration, Intravaginal; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Hemostatic Disorders; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Retrospective Studies; Treatment Outcome; Uterine Hemorrhage; von Willebrand Diseases | 2008 |
Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation; Nausea; Norgestrel; Uterine Hemorrhage | 1983 |
Menstrual blood loss with contraceptive subdermal levonorgestrel implants.
Topics: Adult; Blood Specimen Collection; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Silicone Elastomers; Uterine Hemorrhage | 1981 |
Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate.
Topics: Adult; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Implants; Estradiol; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Ovulation; Progesterone; Progesterone Congeners; Time Factors; Uterine Hemorrhage; Vagina | 1982 |
A cohort study of Norplant implant: side-effects and acceptance.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Cohort Studies; Contraceptive Agents, Female; Drug Implants; Female; Humans; Indonesia; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Pregnancy Rate; Risk Factors; Surveys and Questionnaires; Uterine Hemorrhage | 1995 |
Conserving the cervix at hysterectomy.
Topics: Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Uterine Hemorrhage | 1995 |
Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
Topics: Adult; Biopsy; Drug Implants; Endometrium; Estradiol; Female; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Levonorgestrel; Menstruation Disturbances; Middle Aged; Progesterone; Uterine Hemorrhage; von Willebrand Factor | 1994 |
Use of Norplant implants in a New York City clinic population.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Headache; Humans; Levonorgestrel; New York City; Time Factors; Uterine Hemorrhage; Weight Gain | 1994 |
One-year experience with subdermal contraceptive implants in the United States.
Topics: Adolescent; Adult; Child; Consumer Behavior; Drug Implants; Female; Headache; Humans; Levonorgestrel; Middle Aged; Pregnancy; United States; Uterine Hemorrhage; Weight Gain | 1993 |
Patient satisfaction and side effects with levonorgestrel implant (Norplant) use in adolescents 18 years of age or younger.
Topics: Adolescent; Adult; Drug Implants; Female; Humans; Levonorgestrel; Patient Satisfaction; Psychology, Adolescent; Uterine Hemorrhage; Weight Gain | 1993 |
Hormonal intrauterine devices.
Topics: Adolescent; Adult; Amenorrhea; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pelvic Inflammatory Disease; Pregnancy; Sweden; Uterine Hemorrhage | 1993 |
The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation.
Topics: Adult; Endometrium; Estradiol; Female; Follicular Phase; Humans; Kinetics; Levonorgestrel; Luteal Phase; Progesterone; Uterine Hemorrhage; Uterus | 1995 |
Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
Topics: Atrophy; Biopsy; Contraceptives, Oral, Synthetic; Drug Implants; Endometrium; Endothelins; Estradiol; Female; Humans; Immunohistochemistry; Indonesia; Levonorgestrel; Progesterone; Time Factors; Uterine Hemorrhage | 1995 |
Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Endometrium; Female; Flow Cytometry; Humans; Immunohistochemistry; Intrauterine Devices; Leukocytes; Levonorgestrel; Middle Aged; Phenotype; Uterine Hemorrhage | 1996 |
The introduction of a new contraceptive; two years experience with Norplant.
Topics: Adolescent; Adult; Choice Behavior; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Levonorgestrel; Patient Acceptance of Health Care; Patient Education as Topic; Uterine Hemorrhage | 1996 |
Bleeding complaints during the first year of norplant implants use and their impact on removal rate.
Topics: Adult; Cohort Studies; Drug Implants; Female; Humans; Levonorgestrel; Patient Satisfaction; Retrospective Studies; Uterine Hemorrhage | 1996 |
Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Endometrium; Estradiol; Female; Humans; Hyperplasia; Levonorgestrel; Progesterone; Time Factors; Uterine Hemorrhage | 1996 |
Menstrual bleeding patterns in Norplant-2 implant users.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Uterine Hemorrhage | 1996 |
Endometrial vasculature in Norplant users.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Endometrium; Estrogens; Female; Humans; Levonorgestrel; Time Factors; Uterine Hemorrhage | 1996 |
Endometrial angiogenic response in Norplant users.
Topics: Adolescent; Adult; Biological Assay; Biopsy; Cell Movement; Cells, Cultured; Contraceptive Agents, Female; Endometrium; Endothelium, Vascular; Estradiol; Female; Humans; Levonorgestrel; Neovascularization, Physiologic; Organ Culture Techniques; Progesterone; Sex Hormone-Binding Globulin; Uterine Hemorrhage | 1996 |
Menstrual disorders and progestin contraception. Proceedings of a meeting. Bali, Indonesia, 14-15 October 1995.
Topics: Animals; Contraceptive Agents, Female; Disease Models, Animal; Female; Humans; Levonorgestrel; Menstruation Disturbances; Progesterone Congeners; Uterine Hemorrhage | 1996 |
Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
Topics: Contraceptive Agents, Female; Endometrium; Female; Humans; Immunohistochemistry; Levonorgestrel; RNA, Messenger; Staining and Labeling; Stromal Cells; Thromboplastin; Uterine Hemorrhage | 1997 |
[Vaginal bleeding patterns and the regularity in use of Norplant].
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Uterine Hemorrhage | 1996 |
Treatment of bleeding problems associated with progestin-only contraceptives: survey results.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Surveys and Questionnaires; Uterine Hemorrhage | 1997 |
Commentary: promising results but wider recruitment needed.
Topics: Adult; Female; Humans; Hysterectomy; Levonorgestrel; Middle Aged; Multicenter Studies as Topic; Patient Selection; Progesterone Congeners; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 1998 |
Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use.
Topics: Adult; Choriocarcinoma; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Contraceptive Agents, Female; Drug Implants; Female; Fluorescent Antibody Technique; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Time Factors; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 1998 |
Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B).
Topics: Adult; Biopsy; CD3 Complex; Cell Movement; Collagenases; Drug Implants; Endometrium; Eosinophils; Female; Humans; Immunohistochemistry; Indonesia; Levonorgestrel; Macrophages; Matrix Metalloproteinase 9; Neutrophils; T-Lymphocytes; Tissue Inhibitor of Metalloproteinases; Uterine Hemorrhage | 1999 |
Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrium; Female; Humans; Immunohistochemistry; Levonorgestrel; Mast Cells; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners; Uterine Hemorrhage | 2000 |
Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Topics: Adult; Contraindications; Drug Implants; Endometriosis; Female; Humans; Hysterectomy; Levonorgestrel; Malignant Hyperthermia; Menorrhagia; Progesterone Congeners; Uterine Hemorrhage; Uterus | 1999 |
Intrauterine polyps--a cause of unscheduled bleeding in women using the levonorgestrel intrauterine system: case report.
Topics: Adult; Aged; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Polyps; Uterine Hemorrhage; Uterine Neoplasms | 2000 |
Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users.
Topics: Adult; Aged; Analysis of Variance; Contraception Behavior; Female; Finland; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy, Unwanted; Proportional Hazards Models; Reproductive Medicine; Time Factors; Uterine Hemorrhage; Weight Gain | 2000 |
The measurement of endometrial perfusion in norplant users: a pilot study.
Topics: Adult; Blood Pressure; Contraceptive Agents, Female; Drug Implants; Endometrium; Estradiol; Female; Humans; Laser-Doppler Flowmetry; Levonorgestrel; Menstrual Cycle; Ovary; Pilot Projects; Progesterone; Time Factors; Uterine Hemorrhage | 2000 |
[The changes of sex steroid receptors and morphology in Norplant treated endometrium].
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Levonorgestrel; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Uterine Hemorrhage | 1998 |
Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Menorrhagia; Menstruation; Ovulation; Prospective Studies; Uterine Hemorrhage; Vascular Diseases | 2000 |
Changes in menstrual and haematological indices among Norplant acceptors.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Hematocrit; Humans; Leukocyte Count; Levonorgestrel; Longitudinal Studies; Menstruation; Platelet Count; Uterine Hemorrhage | 2000 |
Efficacy and side effects of immediate postcoital levonorgestrel used repeatedly for contraception. United Nations Development Programme/ United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Re
Topics: Adult; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Treatment Failure; Uterine Hemorrhage | 2000 |
Oxidative stress, vitamin E and progestin breakthrough bleeding.
Topics: Adolescent; Adult; Biopsy; Cells, Cultured; Endometrium; Endothelium, Vascular; Female; Humans; Levonorgestrel; Lipid Peroxides; Medroxyprogesterone Acetate; Neovascularization, Physiologic; Oxidative Stress; Progestins; Uterine Hemorrhage; Vitamin E | 2000 |
Endothelial cell dysfunction following prolonged activation of progesterone receptor.
Topics: Adolescent; Adult; Basement Membrane; Endometrium; Endothelium, Vascular; Female; Humans; Levonorgestrel; Matrix Metalloproteinase 9; Progesterone; Progesterone Congeners; Promegestone; Receptors, Progesterone; RNA, Messenger; Uterine Hemorrhage | 2000 |
Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding.
Topics: Actins; Adult; Antigens, CD34; Contraceptive Agents, Female; Endometrium; Endothelium, Vascular; Female; Humans; Immunohistochemistry; Levonorgestrel; Microcirculation; Muscle, Smooth, Vascular; Uterine Hemorrhage | 2000 |
Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users.
Topics: Adult; Biopsy; Blotting, Western; Contraceptive Agents, Female; Culture Media, Conditioned; Culture Techniques; Drug Implants; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Immunohistochemistry; Levonorgestrel; Luteinizing Hormone; Matrix Metalloproteinase 3; Progesterone; Progesterone Congeners; Uterine Hemorrhage | 2000 |
Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding.
Topics: Apoptosis; Caspase 3; Caspases; Contraceptive Agents, Female; Drug Implants; Endometrium; fas Receptor; Female; Humans; Immunohistochemistry; Levonorgestrel; Progesterone Congeners; Proto-Oncogene Proteins c-bcl-2; Tissue Distribution; Uterine Hemorrhage | 2000 |
Local levonorgestrel to prevent tamoxifen-related endometrial lesions.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Tamoxifen; Uterine Hemorrhage | 2000 |
Norplant users with irregular bleeding. Ultrasonographic assessment and evaluation of serum concentrations of estradiol and progesterone.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Progesterone; Ultrasonography; Uterine Hemorrhage | 2000 |
Contraception with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Topics: Adolescent; Adult; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pilot Projects; Progesterone Congeners; Uterine Hemorrhage | 2000 |
Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health.
Topics: Abdominal Pain; Adult; Breast Neoplasms; Contraceptive Agents, Female; Developing Countries; Drug Implants; Female; Fertility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Marital Status; Ovarian Cysts; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Product Surveillance, Postmarketing; Prospective Studies; Sterilization, Tubal; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms; Vaginal Discharge; Vaginitis | 2001 |
Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Topics: Adult; Drug Delivery Systems; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Pilot Projects; Progesterone Congeners; Time Factors; Uterine Hemorrhage | 2001 |
A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy.
Topics: Cohort Studies; Device Removal; Drug Delivery Systems; Drug Therapy, Combination; Endometrium; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Medical Records; Middle Aged; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 2001 |
Use of the equivalence approach in reproductive health clinical trials.
Topics: Confidence Intervals; Contraception; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Levonorgestrel; Misoprostol; Oxytocics; Pregnancy; Prenatal Care; Randomized Controlled Trials as Topic; Reproductive Medicine; Sample Size; Statistics as Topic; Therapeutic Equivalency; Uterine Hemorrhage | 2001 |
[Study on relationship between endometrium laminin expression and irregular uterine bleeding in Norplant users].
Topics: Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Laminin; Levonorgestrel; Uterine Hemorrhage | 2000 |
[Contraception using a subcutaneous implant, Norplant].
Topics: Adolescent; Adult; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Prospective Studies; Time Factors; Uterine Hemorrhage | 1992 |
Persisting cyclical uterine bleeding in patients treated with radical radiation therapy and hormonal replacement for carcinoma of the cervix.
Topics: Adult; Drug Administration Schedule; Endometrium; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Ovary; Uterine Cervical Neoplasms; Uterine Hemorrhage | 1990 |
A three-year clinical evaluation of Norplant in Singaporean acceptors.
Topics: Adolescent; Adult; Consumer Behavior; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Singapore; Uterine Hemorrhage | 1990 |
[The levonorgestrel intrauterine device].
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstrual Cycle; Norgestrel; Uterine Hemorrhage | 1989 |
Pharmacokinetic studies with a vaginal delivery system releasing levonorgestrel at a near zero order rate for one year.
Topics: Administration, Intravaginal; Contraceptive Devices, Female; Female; Humans; Kinetics; Levonorgestrel; Norgestrel; Sex Hormone-Binding Globulin; Uterine Hemorrhage | 1986 |
Five-year experience with Norplant implants in Assiut, Egypt.
Topics: Adult; Age Factors; Blood Pressure; Body Weight; Egypt; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Norgestrel; Patient Compliance; Pregnancy; Prostheses and Implants; Silicone Elastomers; Uterine Hemorrhage | 1987 |
Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
Topics: Absorption; Adult; Cervix Mucus; Cholesterol; Contraceptives, Oral, Combined; Drug Combinations; Drug Evaluation; Drug Implants; Female; Fertility; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Uterine Hemorrhage | 1985 |